The Stanford center for Human Systems Immunology (CHSI) has set aside funding for a Pilot Project Program. Promising pilot projects will be chosen on scientific merit and strategic alignment with the goals of the foundation. They should contribute to a better understanding of the diseases/syndromes that are the foundation priorities (such as HIV, Malaria, TB, pneumonia, diarrhea, neglected infectious diseases) and/or lead to the development of a technology or service that could contribute the cross-cutting platforms used by grantees or partners funded by the Global Health or Global Development teams at the Foundation.
We are no longer accepting applications.
Look for new funding opportunities in the Spring of 2016.
Amount of Funding
- For faculty proposals: $50,000 to $200,000 per year for 2 years with a possible third year given sufficient progress
- For senior postdoctoral fellows, clinical fellows, or research associates and Instructors: up to $50,000 per year for 2 years
- Stanford Faculty with PI eligibility (with MCL, UTL, and NTL-Research appointments)
- Senior postdoctoral fellows (with a minimum of 2 years) with a faculty mentor
- Clinical fellows with a faculty mentor
- Research associates with a faculty mentor
- Instructors with a faculty mentor (note: Clinical Instructors are not eligible)
- Proposals from women and minorities who are underrepresented in the area of biomedical and behavioral research (African American or Black, Hispanic/Spanish/Latino, American Indian/Alaskan Native, and Native Hawaiian or Other Pacific Islander descent) are particularly encouraged.
- The research focus must involve Bill and Melinda Gates Foundation areas of interest for infectious diseases of the developing world.
The Center for Human Systems Immunology, in the Institute of Immunity, Transplantation and Infection, with funding from The Bill & Melinda Gates Foundation, is pleased to solicit applications for pilot projects. These projects should aim to advance the global health priorities of the foundation in the areas of HIV, TB, Malaria, neglected infectious diseases (e.g. Dengue) and pathogens that cause pneumonia or enteric diseases in the developing world.
There are three general categories for this funding:
- Innovative technologies including major improvements on existing methods that are, or can be, applied to understanding the immune response to a major infectious disease of global health relevance. This may apply to the direct analysis of subjects with active disease or vaccine candidates, or both, as well as to the development of disease models that closely mimic human diseases and responses.
- Innovative analytical tools and algorithms to serve as visualization, analytic and data sharing resources for global health studies involving the generation of high dimensional immune and related biological data. This includes novel approaches designed to increase the power of data mining and predictive modeling that can be readily applied to natural history or vaccine efficacy studies.
- Studies of established cohorts that apply technologies and methods to both new and ongoing studies, or to the analysis of banked samples. Proposals should be designed with the intent to expand the network of investigators working on global health problems, and/or enhance the power of current studies and future areas of need. (Funds cannot be used to start or maintain a clinical or cohort study.)